Nomogram Overview
Survival plot
Download .pdf Download .png
Predicted Survival
Download .pdf Download .png
Note
: the experiment types of expression data are consist of Next generation sequencing(RNA-seq) and Microarray(including GPL570 platform and Non-GPL570 platforms). The
GPL570
is manufactured by Affymetrix, which has complete coverage of the Human Genome U133 Set plus 6,500 additional genes for analysis of over 47,000 transcripts. The rows show the gene symbols and columns represent the tumor patients.
For the RNA-seq example cohorts,
click here
For the GPL570 example profiling(GSE87371),
click here
For the Non-GPL570 example profiling(GSE117556),
click here
Gene and Risk Assessment Database (GRAD-DB) is comprehensive visualization tool that integrates multi-omics datasets, risk stratification model, and clinical features to generate a comprehensive portrait of DLBCL and provide real-time and easily accessible support for clinical decision-making. The main functions are as follow:
Riskscore = 3.54398 × exp(0.13539×C3 – 0.21714×CMSS1 + 0.15708×FABP5 – 0.18063×FAP + 0.19710×ITPRIPL2 – 0.18907×KCTD12 – 0.25097×LMO2 – 0.17834×LYZ – 0.35697×MAL + 0.13280×ODC1 – 0.18192× SSBP3 + 0.26147×ZNF614)